High Hemoglobin A1c but Normal or Low Glucose: How to Find Out Which Number Is Wrong

Oak
hba1c glucose cgm biomarkers genomics
A garnet-feathered reptile specimen on a dark pedestal, translucent neck showing slow red blood cells beneath a fast-pulsing spiral of cyan light.

If your hemoglobin A1c reads 6.1% but every fingerstick and every day of continuous glucose monitoring says your average glucose is 95 mg/dL, one of those two measurements is not describing what you think it describes. A1c is not a glucose measurement. It is the fraction of hemoglobin β-chains carrying a stable ketoamine adduct at the N-terminal valine, integrated over the lifespan of your circulating red cells, and read out by an assay that can be fooled by hemoglobin variants. So discordance has exactly two classes of explanation: your glucose sampling is unrepresentative of your true 24-hour exposure, or your red cell turnover, hemoglobin chemistry, or assay method is shifting the glycated fraction independent of glucose. Both are testable, and the testing is cheap.

First, establish what your true mean glucose is

You cannot call A1c discordant until you have a defensible mean glucose, and fasting fingersticks are not that. Glucose is the archetypal diabetes biomarker precisely because it is dynamic, which also makes single time points poor estimators of integrated exposure.1 A person with a fasting glucose of 92 mg/dL and postprandial peaks of 180 mg/dL lasting 90 minutes three times a day can carry a 24-hour mean in the 120s. That is a normal fasting number and an A1c near 6.0%, and nothing is discordant at all.

Wear a continuous glucose monitor for 14 days and require at least 70% data capture before you trust the summary. Then compute the glucose management indicator, the CGM-derived estimate of A1c:

import pandas as pd

df = pd.read_csv("Clarity_Export.csv")
g = pd.to_numeric(df["Glucose Value (mg/dL)"], errors="coerce").dropna()
# drop calibration and "Low"/"High" sentinel rows first if present
mean_g = g.mean()
gmi = 3.31 + 0.02392 * mean_g
print(f"n={len(g)} mean={mean_g:.1f} mg/dL  GMI={gmi:.2f}%")

Draw the A1c inside that same 14-day window, or at its end, so the two measurements overlap in time. If GMI comes back at 5.4% and the lab A1c is 6.2%, you have a real gap of about 0.8 percentage points and it is worth chasing. If GMI is 5.9% and A1c is 6.1%, you have measurement noise: laboratory A1c has a between-method coefficient of variation of a few percent, and GMI itself carries meaningful individual error because it is fit to a population.

A useful intermediate if you do not have a CGM: smartphone photoplethysmography has been used to build a digital classifier for prevalent diabetes from vascular waveform signals, which shows how much glycemic information leaks into peripheral physiology, though it is a screening signal and not a substitute for measured glucose.2

If the gap is real, look at the red cells

A1c is a product of glucose concentration and red cell exposure time. Anything that lengthens the average age of your circulating erythrocytes raises A1c without raising glucose. Iron deficiency is the common one: lower erythropoiesis means older cells, more accumulated glycation, and A1c inflated by roughly 0.3 to 0.5 percentage points, often more in frank deficiency. Splenectomy, B12 or folate deficiency, and aplastic states do the same. The mirror image also exists: hemolysis, recent transfusion, erythropoietin use, pregnancy, and chronic liver disease shorten red cell survival and push A1c below true glycemia.

So the first orthogonal panel is a complete blood count plus iron studies and a reticulocyte count. The specific fields that matter are hemoglobin, MCV, RDW, absolute reticulocyte count, ferritin, transferrin saturation, and total bilirubin. A low ferritin with high RDW and a low reticulocyte count is a coherent story for an A1c that overstates your glucose. A high reticulocyte percentage with elevated indirect bilirubin points the other way. Interpreting these together, especially if hemoglobin is abnormal, is a clinician’s job, and you should bring the numbers to one rather than acting on them yourself.

Then ask which assay the lab ran

Laboratories measure A1c by several chemistries, and they fail differently. Cation-exchange HPLC separates by charge and will misassign hemoglobin variants that co-elute with A1c. Immunoassays use antibodies against the glycated N-terminus of the β-chain and are sensitive to variants that alter nearby residues. Enzymatic and boronate-affinity methods are generally less variant-sensitive. Carbamylated hemoglobin in uremia, acetylated hemoglobin from sustained high-dose salicylate, severe hypertriglyceridemia, and marked hyperbilirubinemia each interfere in a method-specific way.

Two practical steps. Call the lab and ask for the method name and instrument, then check that method against the NGSP interference tables for the variants relevant to your ancestry. And order an orthogonal glycation marker that does not involve hemoglobin at all: fructosamine or, better, glycated albumin, which reflects roughly the prior two to three weeks and is unaffected by red cell lifespan. If glycated albumin agrees with your CGM and A1c is the outlier, the problem is in the hemoglobin measurement. If glycated albumin agrees with A1c, your CGM window probably was not representative, or you have a genuinely high glycation rate at a given glucose.

Your genome explains part of this

Genome-wide association work on HbA1c separates the signal into glycemic loci, which act through glucose, and erythrocytic loci, which act through red cell biology and shift A1c without shifting glucose. If you have whole-genome sequencing, this is a one-command lookup rather than a guess. The variants worth pulling are rs334 (HBB, sickle), the HbC and HbE alleles in HBB, rs1050828 (G6PD A-, which shortens red cell survival and lowers A1c relative to true glycemia, an effect concentrated in hemizygous men of African ancestry), and the erythrocytic loci around HK1, ANK1, SPTA1, and ATP11A.

bcftools view -R hba1c_loci.bed -i 'GT!="0/0"' sample.g.vcf.gz \
  | bcftools query -f '%CHROM\t%POS\t%ID\t%REF\t%ALT[\t%GT\t%DP\t%GQ]\n'

Check depth and genotype quality before you believe a call; HBB sits in a region where short-read mapping is adequate but coverage dropouts happen, and a DP below about 10 at rs334 is not a result. A heterozygous HbS or HbC call does not mean your A1c is uninterpretable, but it does mean the assay method matters and you should discuss the result with a clinician who can order a hemoglobin fractionation.

There is also a persistent within-person offset, sometimes called the hemoglobin glycation index or glycation gap, that is reproducible across years and partly heritable. Some people simply glycate hemoglobin faster at the same mean glucose. Multi-analyte profiling, including metabolomic panels, is how this kind of individual offset gets characterized rather than dismissed as error.3 The practical consequence is that once you have measured your own gap between GMI and A1c twice, you should treat that offset as a property of you and read future A1c values through it.

The sequence we would run

Wear a CGM for 14 days and compute mean glucose, GMI, time in range, and coefficient of variation. Draw A1c at the end of that window along with a CBC, reticulocyte count, ferritin, transferrin saturation, creatinine, and bilirubin, and add glycated albumin or fructosamine. Record the A1c assay method. Then compare: if GMI, glycated albumin, and A1c all agree, the number is real and you need a clinician, not a better assay. If A1c is the lone outlier, work through red cell lifespan, then variant interference, then your own glycation offset, in that order, because that is the order of decreasing frequency.

Anything acute, including symptoms of very high or very low blood sugar, is a medical emergency and belongs with a clinician immediately, not with a data pipeline.

Questions people also ask

Can your A1c be high but glucose normal? Yes, and it is common. Either your glucose sampling missed postprandial excursions, or your red cells are living longer than average, or your assay is reading a hemoglobin variant as A1c. Measuring 14 days of CGM alongside a CBC and glycated albumin separates those three.

Why is my A1c high when I do not eat sugar? Total carbohydrate, protein-driven gluconeogenesis, cortisol rhythm, sleep debt, and physical inactivity all move 24-hour glucose, and none of them require added sugar. Separately, a high A1c with genuinely low measured glucose points at hemoglobin, not diet.

Can dehydration cause a false high A1c? No. A1c is a ratio of glycated to total hemoglobin, so plasma volume changes cancel out. Dehydration can transiently raise a plasma glucose reading through hemoconcentration, which is a different measurement.

Can drinking water lower A1c? Not through any direct mechanism. Water does not change the glycated fraction of hemoglobin.

Why is my A1c suddenly spiking? A jump of more than about 0.5 percentage points over three months with unchanged CGM data should raise suspicion of a change in assay, lab, or red cell state, such as new iron deficiency or recovery from a bleed, before you conclude glycemia changed.

What is a lethal or stroke-level A1c? There is no such threshold, and we will not give one. A1c is a three-month average and does not define acute risk of any event. Risk stratification across glycemic and cardiovascular markers is done with panels and clinical context, not a single cutoff.4

Oak builds longitudinal molecular profiles of individuals: whole-genome sequencing, RNA sequencing, proteomics, blood biomarkers, and continuous glucose data, integrated into one model of you. Build your profile.

Footnotes

  1. Andrew J Krentz, Marcus Hompesch. Glucose: Archetypal Biomarker in Diabetes Diagnosis, Clinical Management and Research. Biomarkers in Medicine, 2016. https://doi.org/10.2217/bmm-2016-0170 ↩

  2. Robert Avram, Jeffrey E. Olgin, Peter Kuhar, et al. A digital biomarker of diabetes from smartphone-based vascular signals. Nature Medicine, 2020. https://doi.org/10.1038/s41591-020-1010-5 ↩

  3. Abdellah Tebani, Soumeya Bekri. Paving the Way to Precision Nutrition Through Metabolomics. Frontiers in Nutrition, 2019. https://doi.org/10.3389/fnut.2019.00041 ↩

  4. Lavanya Garady, Ashok Soota, Yogesh Shouche, et al. A Narrative Review of the Role of Blood Biomarkers in the Risk Prediction of Cardiovascular Diseases. Cureus, 2024. https://doi.org/10.7759/cureus.74899 ↩